The Drug Tariff price for co-proxamol has been increased dramatically following the withdrawal of the marketing authorisations at the end of 2007.
In December 2007, co-proxamol was listed as Category M with a reimbursement price of £2.79 for 100 tablets. In January 2008 it has been changed to Category C with a reimbursement price of £20.36. This equates to a seven-fold price increase.
Action: Clinicians will already be aware of the withdrawal of the marketing authorisations. The incentive to change as many patients as possible to alternative products is now greater following this substantial price increase.
|« Coxibs for patients on low dose aspirin?||FDA issue fentanyl warning »|